loader
Please Wait
Applying Filters...
menu
    • menu

    Setid A3c356d7 90de 499a 9aa3 A857df89a315 Applno 203629 Form Solution Intravenous Dosage 5mg 10ml 0 5mg Ml - Drug Product Composition: Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate

    Menu

    Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,030Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 203629 / DOSAGE - SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    NEOSTIGMINE METHYLSULFATE(UNII: 98IMH7M386)
    (NEOSTIGMINE - UNII:3982TWQ96G)     		NEOSTIGMINE METHYLSULFATE1mg in 1

    Inactive Ingredients

    Ingredient Name
    American Regent, Inc.
    Avadel Legacy Pharmaceuticals, LLC
    BluePoint Laboratories
    General Injectables and Vaccines, Inc
    REMEDYREPACK INC.
    ACETIC ACID(Q40Q9N063P)
    PHENOL(339NCG44TV)
    SODIUM ACETATE(4550K0SC9B)
    SODIUM HYDROXIDE(55X04QC32I)
    WATER(059QF0KO0R)